X0202
SCHEDULE 13G/A
0001104659-25-009441
0001325083
XXXXXXXX
LIVE
1
Common Stock, par value $0.01 per share
07/01/2026
0001601485
Elicio Therapeutics, Inc
28657F103
451 D Street, 5th Floor
Boston
MA
02210
Rule 13d-1(c)
Knoll Capital Management, LLC
b
FL
0.00
1211957.00
0.00
1211957.00
1211957.00
N
5.3
OO
LLC
Fred Knoll
b
X1
0.00
1211957.00
0.00
1211957.00
1211957.00
N
5.3
IN
Gakasa Holdings, LLC
b
X1
0.00
1211957.00
0.00
1211957.00
1211957.00
N
5.3
OO
Gakasa Holdings, LLC beneficially owns 1,211,957 shares of the Issuer's Common Stock. Knoll Capital Management has trading authority for Gakasa, and Fred Knoll is the President of Knoll Capital Management, LLC.
Elicio Therapeutics, Inc
451 D Street, 5th Floor Boston, MA, 02210
Knoll Capital Management, LLC. Fred Knoll. Gakasa Holdings LLC.
201 S. Biscayne Blvd suite 800, Miami, FL 33131
USA
Y
1,211,957
5.3%
0
1,211,957
0
1,211,957
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยง 240.14a-11.
Knoll Capital Management, LLC
Fred Knoll
President
07/07/2026
Fred Knoll
Fred Knoll
Fred Knoll
07/07/2026
Gakasa Holdings, LLC
Fred Knoll
By, Knoll Capital Management LLC, President
07/07/2026